GlassScriptPhysician profile
Amie Nicole Stringfellow
NPI 1053565028
$910.71
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $82.50 · 2020: $290 · 2021: $38.57 · 2022: $92.11 · 2023: $179 · 2024: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $408.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $407.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $231.99 | 2020-2024 | Wakix |
| Lilly USA, LLC | $152.15 | 2019-2024 | Mounjaro |
| Astrazeneca Pharmaceuticals LP | $132.12 | 2019-2024 | Airsupra |
| Jazz Pharmaceuticals INC. | $79.33 | 2019-2020 | |
| Axsome Therapeutics, INC. | $54.82 | 2023 | Sunosi |
| Azurity Pharmaceuticals, INC. | $47.00 | 2024 | Horizant |
| Novo Nordisk INC | $46.59 | 2020-2023 | Ozempic, Rybelsus, Tresiba |
| Supernus Pharmaceuticals, INC. | $44.66 | 2024 | Qelbree |
| Amgen INC. | $29.54 | 2020-2023 | Prolia, Evenity |
| Pfizer INC. | $24.23 | 2024 | |
| Exact Sciences Corporation | $21.00 | 2024 | Cologuard Collection Kit |
| Mckesson Medical-Surgical, INC. | $20.00 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $16.46 | 2022 | |
| Allergan, INC. | $10.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amie Stringfellow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.